Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,163
Closed -$9.57K 182
2025
Q2
$9.57K Hold
21,163
﹤0.01% 167
2025
Q1
$8.61K Hold
21,163
﹤0.01% 137
2024
Q4
$14K Sell
21,163
-4,837
-19% -$3.36K 0.01% 123
2024
Q3
$22.1K Hold
26,000
0.01% 112
2024
Q2
$17.4K Hold
26,000
0.01% 87
2024
Q1
$19K Hold
26,000
0.01% 86
2023
Q4
$14.9K Hold
26,000
0.01% 75
2023
Q3
$19.6K Hold
26,000
0.01% 72
2023
Q2
$19K Buy
26,000
+6,000
+30% +$5.58K 0.01% 70
2023
Q1
$15.1K Buy
20,000
+1,500
+8% +$1.39K 0.01% 78
2022
Q4
$17.8K Buy
18,500
+6,500
+54% +$9.19K 0.01% 71
2022
Q3
$26K Hold
12,000
0.02% 49
2022
Q2
$53K Hold
12,000
0.04% 48
2022
Q1
$60K Hold
12,000
0.05% 50
2021
Q4
$75K Buy
+12,000
New +$81.9K 0.05% 51

Other funds holding VXRT

Fi3 Financial Advisors's VXRT Position: Q3 2025 in Review

Fi3 Financial Advisors sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 21,163 shares — an estimated $9.57K sold.

Fi3 Financial Advisors first reported a position in VXRT in Q4 2021 and held it in 15 quarters. The position peaked at $75K in Q4 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Fi3 Financial Advisors reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Fi3 Financial Advisors sold 21,163 Vaxart shares in Q3 2025, an estimated $9.57K.
  • Fi3 Financial Advisors first reported a position in Vaxart in Q4 2021 and held it in 15 quarters.
  • Fi3 Financial Advisors's Vaxart position peaked at $75K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Fi3 Financial Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.